Journal of the European Academy of Dermatology and Venereology

Article	Citations
Editor's Picks	234
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	158
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	156
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination	144
The significance of exanthems in COVID‐19 patients hospitalized at a tertiary care centre	130
The role of genetic factors and peripheral immune cells in SAPHO syndrome	129
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	126
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	112
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	102
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	92
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	91
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	79
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	72
Are non‐fungible tokens the barrier to realizing the Dermoverse?	71
Announcement	63
Pharmacovigilance: The responsibility of all	63
Chat GPT in dermatology: Progressive or problematic?	62
Announcement	62
	61
Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach	60
Rosacea and upper gastrointestinal disorders: a case‐control study from a large, urban academic centre	59
Dalbavancin for the treatment of severe hidradenitis suppurativa	59
Impact of menopause on the skin…information still insufficient	55
Announcement	53
Editor's Picks January 2024	52

Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	52
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	52
Announcement	51
Issue Information	49
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	48
A case of eruptive halo nevi following COVID‐19	46
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	45
Peer review, scientific publishing and the law of reciprocity	45
The chicken or the egg of lymphopenia in atopic eczema	45
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	45
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	42
Louis Adolphus Duhring: An enduring legacy	42
	42
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	42
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	42
Educational, labour market and relationship outcomes in people with acne	41
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	41
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	41
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	40
The future of digital pills and their potential use in dermatological clinical trials	40
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	40
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	40
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	40
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	39
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	39
Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination	38
A new era for alopecia areata: New treatments and improved knowledge of the condition	38
Two cases of cerebrovascular accidents following the induction dose of risankizumab	37
Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10%	37
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	36
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine	36
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	36
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	35
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–2019	35
Application of integrated skincare in medical aesthetics: A literature review	35
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	34
Urinary incontinence and female genital lichen sclerosus	34
Efficacy of imiquimod in the management of lentigo maligna	34
Flagellate purpura associated with COVID‐19 vaccination	34
Mucocutaneous leishmaniasis complicating systemic lupus erythematosus and responding to high dose amphotericin B	34
	33
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	33
Issue Information	33
Announcement	33
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	32
Juvenile localized scleroderma: A single‐centre experience from India	32
Cutaneous reactions to inactivated SARS‐CoV‐2 vaccine and ChAdOx1‐S (recombinant) vaccine against SARS‐CoV‐2: a case series from the Philippines	32
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	31
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	31
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort	31

Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis	30
Advances in biologic therapy of psoriasis	30
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	30
	30
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	30
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	30
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US	30
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	30
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	30
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	30
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	29
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	29
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	29
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	29
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	29
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	29
Biomarkers in rosacea: A systematic review	28
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	28
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	28
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study	28
Announcement	28
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	28
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	28
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	28
Oral and genital suction purpura	27
Pioneers in Dermatology and Venereology: an interview with Professor Francisco Miguel Camacho Martinez	27
Announcement	27
Non‐coeliac gluten sensitivity: an underdiagnosed condition in dermatology?	27
Penile nodules as a manifestation of lymphogranuloma venereum: an underrecognized form	27
Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies	27
Basal cell carcinoma on the ventral site of the finger with an intronic deletion of SUFU gene	27
Reflectance confocal microscopy features of uncommon histopathological variants of cutaneous melanoma	27
Chronic urticaria – From ‘Cinderella’ to a ‘Rock star’ in 30 years	26
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	26
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	26
	26
Issue Information	26
Commentary to ‘Development of a patient‐reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.	26
	26
	26
Morphoea en coup de sabre with Adie's pupil: An exceptional association	26
Incidence and remission rates of self‐reported hidradenitis suppurativa ‐ A prospective cohort study conducted in Danish blood donors	26
Announcement	26
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	26
Drug reaction with eosinophilia and systemic symptoms in a 10‐year‐old boy sparing lichen planus lesions: an example of reverse isotopic response	26
Announcement	25
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	25
Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients	25
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	25
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	25
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	25
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	25
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	25
The art of observation: visual literacy for dermatologists	24
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	24
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	24
Stevens‐Johnson syndrome induced by Vaxvetria (AZD1222) COVID‐19 vaccine	24
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	24
Hidradenitis suppurativa‐specific, patient‐reported outcome measures	24
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	24
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	24
Scabies revisited in the COVID‐19 era	24
Are the chilblain‐like lesions observed during the COVID‐19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta‐analysis	24
	24
Announcement	24
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	23
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	23
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	23
New regulation of medical devices in the EU: impact in dermatology	23
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	23
Systematic review of single and combined treatments for different types of striae: a comparison of striae treatments	23
Dermatitis herpetiformis triggered by iodine contrast media	23
Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients	23
Burnout among French dermatologists: A national study	22
Delayed cutaneous reaction to ChAdOx1 nCoV‐19 vaccine: Is it an ‘AstraZeneca arm’?	22
Deciphering differential response to NB‐UVB: The hair matters	22
A special thank you to our reviewers!	22
Herpes zoster after ChAdOx1 nCoV‐19 vaccine: a case series	22
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	22
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction	22

Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	22
Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics	22
	22
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	21
Beyond the surface: Integrating sex and gender in dermatologic therapy	21
Effectiveness and safety of apremilast in biologic‐naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study	21
Successful treatment with narrowband ultraviolet B phototherapy in prurigo pigmentosa	21
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	21
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	21
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	21
	21
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	21
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	21
Chronic pruritus in multiple sclerosis and clinical correlates	20
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature	20
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	20
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	20
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	20
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	20
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	20
2021 European guideline on the management of Mycoplasma genitalium infections	20
Announcement	20
The watch sign: an atypical clinical finding of frontal fibrosing alopecia in two male patients	20
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	20
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	20
Paediatric mycosis fungoides – characteristics, management and outcomes with particular focus on the folliculotropic variant	20
Is risankizumab as needed administration a good option for patients with plaque psoriasis?	20
Sensitivity of clinician‐assessed efficacy outcome measurement instruments in trials of topical therapies for atopic dermatitis: a systematic review and meta‐analysis	20
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	20
Announcement	20
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	20
Analysis of the structure and function of the epidermal barrier in patients with ichthyoses—clinical and electron microscopical investigations	20
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	20
Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics	20
Erectile dysfunction in patients with seborrhoeic dermatitis	20
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	20
Announcement	19
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	19
From COVID‐19 to war – life of a dermatological journal in times of crisis	19
Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid	19
Racial representation in dermatology clinical trials, a Canadian perspective	19
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	19
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	19
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	19
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	19
Neuropathy as an early warning sign of desmoplastic neurotropic melanoma of the head	19
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	19
Store‐and‐forward mobile application as an accessible method of study participant assessment	19
Advances in image‐based diagnosis of nail disorders	18
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023	18
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	18
Probing into functional decline among bullous pemphigoid patients	18
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study	18
Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’	18
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study	18
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	18
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb ran	18
Improvement of redness and hyperkeratosis in a case of Nagashima‐type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis	18
Delayed hypersensitivity of hyaluronidase: a case report	18
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	18
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	18
The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico‐histopathologic presentation	18
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	18
Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up	18
Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study	18
Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study	18
Alopecia universalis improvement following risankizumab in a psoriasis patient	18
Is Scabies becoming less sensitive to permethrin therapy?	18
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	17
Issue Information	17
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients	17
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature	17
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	17
Thirty years of promoting sun safety in France: The messages are heard but not followed!	17
False negative RPR test with prozone phenomenon in an HIV‐negative man with secondary syphilis	17
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	17
Announcement	17
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	17
Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain‐of‐function mutation	17
Lentigo maligna: A retrospective analysis of 50 cases treated with imiquimod monitored with non‐invasive reflectance confocal microscopy	17
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide‐scale cohort study	17
Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LON	17
Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?	17
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	17
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study	17
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	17
Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature	17
Merkel cell carcinoma after solid organ transplant	17
Non‐invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM‐OCT imaging device: a case‐series	17
	17
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	17
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	16
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	16
Premature skin ageing signs due to androgen deprivation therapy	16
Sensitive skin: A relevant syndrome, be aware	16